291 related articles for article (PubMed ID: 25404023)
1. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
[TBL] [Abstract][Full Text] [Related]
2. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
[TBL] [Abstract][Full Text] [Related]
3. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.
Zhang Y; Shi L; Li S; Yang Z; Standley C; Yang Z; ZhuGe R; Savidge T; Wang X; Feng H
PLoS One; 2013; 8(3):e58634. PubMed ID: 23484044
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
Li S; Shi L; Yang Z; Feng H
Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.
Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar RH; Mikelsaar M; Verrips T; Hammarström L; Marcotte H
Infect Immun; 2016 Feb; 84(2):395-406. PubMed ID: 26573738
[TBL] [Abstract][Full Text] [Related]
6. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
Zhang Y; Hamza T; Gao S; Feng H
Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
[TBL] [Abstract][Full Text] [Related]
7. A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.
Wang YK; Yan YX; Kim HB; Ju X; Zhao S; Zhang K; Tzipori S; Sun X
Hum Vaccin Immunother; 2015; 11(9):2215-22. PubMed ID: 26036797
[TBL] [Abstract][Full Text] [Related]
8. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.
Rupnik M; Pabst S; Rupnik M; von Eichel-Streiber C; Urlaub H; Söling HD
Microbiology (Reading); 2005 Jan; 151(Pt 1):199-208. PubMed ID: 15632438
[TBL] [Abstract][Full Text] [Related]
10. Cysteine Protease-Mediated Autocleavage of
Zhang Y; Li S; Yang Z; Shi L; Yu H; Salerno-Goncalves R; Saint Fleur A; Feng H
Cell Mol Gastroenterol Hepatol; 2018; 5(4):611-625. PubMed ID: 29930981
[TBL] [Abstract][Full Text] [Related]
11. Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.
Yang Z; Zhang Y; Huang T; Feng H
Gut Microbes; 2015 Jul; 6(4):221-4. PubMed ID: 26091306
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
[TBL] [Abstract][Full Text] [Related]
13. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
Egerer M; Giesemann T; Herrmann C; Aktories K
J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.
Chumbler NM; Farrow MA; Lapierre LA; Franklin JL; Haslam DB; Goldenring JR; Lacy DB
PLoS Pathog; 2012; 8(12):e1003072. PubMed ID: 23236283
[TBL] [Abstract][Full Text] [Related]
15. Metal Ion Activation of Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B.
Genth H; Schelle I; Just I
Toxins (Basel); 2016 Apr; 8(4):109. PubMed ID: 27089365
[TBL] [Abstract][Full Text] [Related]
16. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.
Yang Z; Ramsey J; Hamza T; Zhang Y; Li S; Yfantis HG; Lee D; Hernandez LD; Seghezzi W; Furneisen JM; Davis NM; Therien AG; Feng H
Infect Immun; 2015 Feb; 83(2):822-31. PubMed ID: 25486992
[TBL] [Abstract][Full Text] [Related]
18. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J
J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961
[TBL] [Abstract][Full Text] [Related]
20. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
[No Abstract] [Full Text] [Related]
[Next] [New Search]